Nephrology, Dialysis, Transplantation
Efficacy and safety of canagliflozin are consistent across polypharmacy burden in CKD: the CREDENCE trial
Randomised trial in 4,401 peopleCanagliflozin
Papers by Soo Kun Lim
2 results
- Research Square
Applicability of Mayo’s Autosomal Dominant Polycystic Kidney Disease (ADPKD) Prognostic Tool in the Southeast Asian ADPKD Population
Preprint: study in peopleBiomarkers